Warby Parker (WRBY) Stock Forecast & Price Target

$14.56

-0.32 (-2.15%)

(As of 09/18/2024 ET)

Warby Parker - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 9 Analyst Ratings

Based on 9 Wall Street analysts who have issued ratings for Warby Parker in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 9 analysts, 4 have given a hold rating, and 5 have given a buy rating for WRBY.

Consensus Price Target

$17.11
17.52% Upside

High Forecast	$20.00
Average Forecast	$17.11
Low Forecast	$14.00

According to the 9 analysts' twelve-month price targets for Warby Parker, the average price target is $17.11. The highest price target for WRBY is $20.00, while the lowest price target for WRBY is $14.00. The average price target represents a forecasted upside of 17.52% from the current price of $14.56.

Type	Current Forecast 9/20/23 to 9/19/24	1 Month Ago 8/21/23 to 8/20/24	3 Months Ago 6/22/23 to 6/21/24	1 Year Ago 9/20/22 to 9/20/23
Consensus Rating	Moderate Buy	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$17.11	$16.57	$16.50	$18.00
Forecasted Upside	17.52% Upside	14.08% Upside	15.43% Upside	25.94% Upside

Who are Nvidia’s New Silent Partners? (Ad)

Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.

I call these Nvidia’s “Silent Partners.”

WRBY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

WRBY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Warby Parker Stock vs. The Competition

Type	Warby Parker	Medical Companies	S&P 500
Consensus Rating Score	2.56	2.77	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	17.52% Upside	1,007.90% Upside	7.93% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
8/23/2024	Piper Sandler 2 of 5 stars		Initiated Coverage	Overweight	$18.00	+29.87%
8/23/2024	JMP Securities 2 of 5 stars	N. Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$20.00	+44.30%
8/9/2024	Stifel Nicolaus 4 of 5 stars		Boost Target	Hold ➝ Hold	$14.00 ➝ $15.00	+6.99%
8/8/2024	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$19.00 ➝ $19.00	+32.77%
7/10/2024	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$15.00 ➝ $16.00	+1.65%
5/10/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$13.00 ➝ $15.00	+0.07%
War on Elon Escalates… (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it.
5/10/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$13.00 ➝ $14.00	-7.59%
10/12/2023	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$17.00	+19.63%
10/3/2023	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	In-Line ➝ Outperform	$20.00	+50.77%
8/11/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$13.00 ➝ $14.00	+4.48%
6/27/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform
5/10/2023	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$20.00 ➝ $18.00	+48.39%
3/1/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$23.00 ➝ $17.00	+30.67%
12/15/2022	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$20.00	+28.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:31 AM ET.

WRBY Forecast - Frequently Asked Questions

What is Warby Parker's forecast for 2024?: According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Warby Parker is $17.11, with a high forecast of $20.00 and a low forecast of $14.00.
Should I buy or sell Warby Parker stock right now?: 9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Warby Parker in the last twelve months. There are currently 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" WRBY shares.
Does Warby Parker's stock price have much upside?: According to analysts, Warby Parker's stock has a predicted upside of 19.01% based on their 12-month stock forecasts.
Has Warby Parker been upgraded by Wall Street analysts recently?: Over the previous 90 days, Warby Parker's stock had 1 upgrade by analysts.
What analysts cover Warby Parker?: Warby Parker has been rated by research analysts at JMP Securities, Loop Capital, Piper Sandler, Stifel Nicolaus, and Telsey Advisory Group in the past 90 days.
Do Wall Street analysts like Warby Parker more than its competitors?: Analysts like Warby Parker less than other "medical" companies. The consensus rating score for Warby Parker is 2.56 while the average consensus rating score for "medical" companies is 2.77. Learn more on how WRBY compares to other companies.